| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/15/2004 | WO2003019142A3 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 04/15/2004 | WO2003012062A9 Animal model with disrupted fgf14 gene |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002097029A3 Plate and method for high throughput screening |
| 04/15/2004 | WO2002086094A3 Genes involved in isoprenoid compound production |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002064763A8 Novel human poly(a)polymerase gamma (pap gamma) |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002059297A8 A library of a collection of cells |
| 04/15/2004 | WO2002059296A8 Concatemers of differentially expressed multiple genes |
| 04/15/2004 | WO2002059290A8 A method for evolving a cell having desired phenotype and envolved cells |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002031157A8 Shrimp alkaline phosphatase |
| 04/15/2004 | WO2002024872A8 Manipulation of spermatozoa |
| 04/15/2004 | WO2002018546A9 Plasma-derived-fibrin-based matrices and tissue |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073970 Transgenic magnaporthe resistant rice; tissue engineering; horticulture |
| 04/15/2004 | US20040073966 Preparing and propagating transgenic isoxafutole resistant maize; enzyme inhibitors |
| 04/15/2004 | US20040073964 Using washing media containing polysaccharide containing arabinose, galactose and fatty acid units; activation ; storage; prevent cellular damage |
| 04/15/2004 | US20040073391 Small hepatocyte-rich colonies, process for preparing the colonies, process for maturating the colonies into liver tissue and method of estimating effects of drug by using matured small hepatocyte-rich colonies |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073004 Comprises Ajuba like protein for diagnosis, prevention and treatment of cell proliferative, cardiovascular and neurodegenerative disease |
| 04/15/2004 | US20040073003 Neuromedin u delta |
| 04/15/2004 | US20040073001 Beta-catenin nuclear localized protein |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072999 Novel protein inhibitor of apoptosis proteins |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072793 Amide derivatives; scaffold for tissue regeneration; drug delivery biodegradable; tissue adhesive |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072747 Novel member of the epha receptor family |
| 04/15/2004 | US20040072350 Process for producing normal parenchymal cells tissue or organ by bioincubator |
| 04/15/2004 | US20040072349 Serum-free eukaryotic cell culture nutrient broth for propagating blood and myeloid lineage cells; hematology |
| 04/15/2004 | US20040072348 Trangenic dendritic cell culture for use in treatment and prevention of transplant rejection and autoimmune diseases |
| 04/15/2004 | US20040072347 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 04/15/2004 | US20040072346 Transgenic neuronal tissue for propagation and treatment of brain disorders; tissue engineering and gene therapy |
| 04/15/2004 | US20040072345 Proliferating mammalian cells from central nervous system into neurons for use in treatment of neurodegenerative diseases; antitumor/antiproliferative agents |
| 04/15/2004 | US20040072344 Differentiating pluripotent stem cells into pancreatic or nervous system tissues for treatment of nervous system and pancreatic disorders; transplant therapy; tissue engineering |
| 04/15/2004 | US20040072343 Cell reprogramming |
| 04/15/2004 | US20040072342 Synthetic polypeptide for forming cultured endothelial cells into tubes within three-dimensional gel with subsequent grafting into animals; organ transplantation; tissue engineering; neovascularization |
| 04/15/2004 | US20040072338 Apparatus comprising water-containing polymer gel for tissue propagation; tissue engineering |
| 04/15/2004 | US20040072326 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 04/15/2004 | US20040072317 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses |
| 04/15/2004 | US20040072300 Comprises expression vector coding cytokines/immunoglobulin fusion protein for treating tumor and autoimmune disorders; immunotherapy; antitumor agents |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072298 Comprises homeobox gene protein for enhancing hematopoietic stem cell expansion by direct delivery of protein to cell; gene therapy |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072294 Generating morphogens associated with extracellular matrix for reconstructing damaged or injured tissues; tissue engineering |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072288 Methods for altering cell fate to generate T-cells specific for an antigen of interest |
| 04/15/2004 | US20040072287 Cell lines expressing a mch receptor |
| 04/15/2004 | US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis |
| 04/15/2004 | US20040072281 Fixed tumor, nerve, glial, muscle and blood cells; microscopic tissue fixation and disease diagnosis |
| 04/15/2004 | US20040072270 Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
| 04/15/2004 | US20040072264 Comprises nucleotide sequences coding ca protein (CAP) for diagnosing and treating cell proliferative disorders; antiproliferative agents |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072254 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072178 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producng protein capable of regenerating luciferin |
| 04/15/2004 | US20040072177 Novel human serine-threonine kinase |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072154 Novel compositions and methods for cancer |
| 04/15/2004 | US20040072141 Producing semen via xenogenic tissue grafting of testis in animal models; preserving fertility in prepubescent males undergoing chemotherapeutic treatment |
| 04/15/2004 | US20040072140 Freeze dried lymphocytes for vaccine development; immunotherapy |
| 04/15/2004 | US20040072139 Photodynamic treatment and uv-b-irradiation of a thrombocyte suspension |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071702 Homologous recombination, heavy chain peptides, amino acid sequences, light chain peptides, for treating inflammatory disorders, rheumatoid arthritis, psoriasis, transplant rejections and cancers |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071695 Novel g-protein coupled receptor |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071678 Method of producing genetically modified astrocytes and uses thereof |
| 04/15/2004 | US20040071675 Retrograde transport delivering entity of interest to tyrosine hydroxylase positive neuron; Parkinson's disease; rabies g protein transduction |
| 04/15/2004 | US20040071674 Directly implanting; permanent engrafting; stably expressing variety of gene products; differentiating into specialized cells; nitric oxide synthase |
| 04/15/2004 | US20040071673 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 04/15/2004 | US20040071672 Giving rise to embryoid bodies and multiple differentiated cell phenotypes in monolayer culture; can be maintained on feeder layers for at least 20 passages; nonmouse mammalian |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071670 Transplantation cell kits for re-myelination of nerve cells |
| 04/15/2004 | US20040071669 Transplants for myocardial scars |
| 04/15/2004 | US20040071667 Use of cytokines and mitogens to inhibit pathological immune responses |
| 04/15/2004 | US20040071665 Introducing inoculum to heart consisting of at least two of stem, progenitor, lineage committed and differentiated cells to develop in situ as integrated cells |